TWi Pharmaceuticals announced the launch of Megestrol Acetate Suspension, the generic version of Par Pharmaceutical’s Megace ES.

Megace ES is a progestin indicated for the treatment of anorexia, cachexia, or unexplained significant weight loss in patients diagnosed with AIDS. It is intended to help improve appetite and gain weight. The precise mechanism by which megestrol acetate produces effects in anorexia and cachexia is unknown.

RELATED: Migraine Med Linked to Eating Disorders in Teens

Megestrol Acetate Suspension is available as a 125mg/mL strength concentrated suspension in 5oz bottles.

For more information visit